Working Overtime Raises Heart Disease Risk: The study found that, compared with people who did not work overtime, people who worked three or more hours longer than a normal, seven-hour day had a 60 percent higher risk of heart-related problems such as death due to heart disease, non-fatal heart attacks …
Read More »Newsflash #521
Once Weekly Byetta (Bydureon © ) Delayed 6 Months by the FDA: See this week’s Item #14. FDA Orders Recall of Baxter’s Colleague Volumetric Infusion Pumps: The FDA has notified health care professionals and consumers of a letter sent to Baxter on April 30 ordering the company to recall and …
Read More »Diabetes Nerve Pain May Worsen at Night
Diabetes Nerve Pain May Worsen at Night: People with diabetic peripheral neuropathy report worst pain at 11 p.m., study finds. People with diabetes-related nerve damage may experience worse pain in the evening hours, preliminary research suggests. If confirmed in larger studies, the findings suggest that people with diabetic peripheral neuropathy …
Read More »Sixty Percent of Americans Concerned About Diabetes but Only 30 Percent Take Action
Sixty Percent of Americans Concerned About Diabetes but Only 30 Percent Take Action: Most Americans are concerned about developing diabetes, but a recent study indicates that many of them have not taken the necessary steps to postpone or avoid the disease. The International Diabetes Center and pharmaceutical company Abbott found …
Read More »Newsflash #520
FDA orders recall of Baxter’s Colleague Volumetric Infusion Pumps: The FDA has notified health care professionals and consumers of a letter sent to Baxter on April 30 ordering the company to recall and destroy all Colleague Volumetric Infusion Pumps currently used in the United States — there may be as …
Read More »Changes in Glitazone Use 2003-2009
Changes in Glitazone Use 2003-2009: From 2003 through 2005, glitazone use increased steadily. From February 2005 to January 2007, rosiglitazone use decreased by 16% annually while pioglitazone use increased at an annual rate of 14%. During a period of FDA advisories, rosiglitazone use declined sharply from 0.42 million monthly treatment …
Read More »Mortality Rates Differ with Different Sulfonylureas
Mortality Rates Differ with Different Sulfonylureas: The risk for overall mortality is similar in patients with Type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy, according to the results of a retrospective cohort study. The findings suggest that glimepiride may be the preferred sulfonylurea in patients with underlying coronary artery …
Read More »Newsflash #519
Diabetes Linked to Irregular Heartbeat. See this week’s Item #2. Lilly Submits Reply to FDA Complete Response Letter for BYDUREON™. See this week’s Item #7.
Read More »US Ponders Populationwide Salt-reduction Policies
US Ponders Populationwide Salt-reduction Policies: In most developed countries, more than 75% of the salt consumed comes from processed foods. The WHO advises that adults consume no more than 5g per day. The average consumption of salt in most Western countries currently stands at around 9g to 12g a day. …
Read More »Altitude Could Be Linked to Insulin Sensitivity and Diabetes
Altitude Could Be Linked to Insulin Sensitivity and Diabetes: New research indicates that some people do not develop diabetes even while eating a high-fat diet. According to the recent research, mice that lack the enzyme FIH (the same that influences the way the body responds to low oxygen levels and …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.